secwatch.observer — SEC 8-K summary
======================================

Issuer:     DBV Technologies S.A. (DBVT)
CIK:        0001613780
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001193125-26-197921
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DBV Technologies reports Q1 net loss of $47.6M; cash of $229M into Q2 2027
--------------------------------------------------------------------------

- Net loss of $47.6M ($0.11 per share) vs $27.1M ($0.26) in Q1 2025; loss per share improved due to equity base from PIPE.
- Cash and cash equivalents $229M as of March 31, 2026, up from $194M at year-end 2025; funding into Q2 2027.
- R&D expenses rose to $33.4M (from $21.5M) driven by COMFORT Toddlers study, BLA readiness, and pre-commercial inventory build.
- SG&A expenses increased to $10.5M (from $5.6M) as company builds U.S. commercial infrastructure ahead of potential launch.
- BLA submission for VIASKIN Peanut Patch (ages 4-7) planned H1 2026; toddler BLA H2 2026; Phase 2 THRIVE study in infants planned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613780/000119312526197921/0001193125-26-197921-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613780/000119312526197921/d132063d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-197921

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer